It was without question a very challenging time in the early 2000s, as global pharmaceutical companies restructured their research enterprise. A number of organizations, like one of our predecessor organizations, grew out of that. We took over and acquired the research hub of a global player in Ville Saint-Laurent, and we have turned it into a vibrant innovation centre in Canada.
It is actually very exciting to see the kind of growth and development in Canada, and the attitudinal shift of researchers and entrepreneurs in Canada to build here the companies that can grow and scale here to be globally competitive. When we first started out, let's say five years ago, one of the things that distinguished Canada relative to our competitors globally was that we were the only advanced pharma market in the world without a domestic research-based anchor company by the classic definition. We find ourselves today with certainly two anchor companies by that definition and probably, depending on whom you want to ask, 10 to 12 putative anchor companies.
I'm very excited about the growth that's happening in this space. There is lots more to do, but I think Canada is absolutely poised to lead the world in this regard.